| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/19/1999 | CA2320154A1 Use of hyperforin and hyperforin-containing extracts for the treatment and prophylaxis of dementia diseases |
| 08/19/1999 | CA2320132A1 Pressure sensitive adhesive matrix patch for the treatment of onychomycosis |
| 08/19/1999 | CA2320091A1 Stable hyperforin salts, methods of manufacturing them, and their use for the treatment of alzheimer's disease |
| 08/19/1999 | CA2319740A1 Oral liquid formulations of benzoxazinones hiv reverse transcriptase inhibitors |
| 08/19/1999 | CA2319492A1 Novel dimerizing agents, their production and use |
| 08/19/1999 | CA2319424A1 Processes and intermediates useful to make antifolates |
| 08/19/1999 | CA2319173A1 Novel cyclic sulfonamide derivatives as metalloproteinase inhibitors |
| 08/19/1999 | CA2319134A1 Novel means and methods for the preparation and activation of nucleoside and nucleotide based drugs |
| 08/19/1999 | CA2319082A1 Bicyclic pyrrole derivatives as mcp-1 inhibitors |
| 08/19/1999 | CA2319009A1 2-(purin-9-yl) -tetrahydrofuran-3, 4-diol derivatives |
| 08/19/1999 | CA2318975A1 Prodrugs of 2'3'-dideoxy-3'-fluoro guanosine |
| 08/19/1999 | CA2318966A1 Biaryl-acetic acid derivatives and their use as cox-2 inhibitors |
| 08/19/1999 | CA2318957A1 Antagonists of gonadotropin releasing hormone |
| 08/19/1999 | CA2318347A1 Heterocyclic topoisomerase poisons |
| 08/19/1999 | CA2317456A1 Chemical compounds |
| 08/19/1999 | CA2317451A1 Antagonists of gonadotropin releasing hormone |
| 08/19/1999 | CA2316264A1 Novel triazolo(4,5-d)pyrimidine compounds |
| 08/19/1999 | CA2315735A1 Substituted aminophenyl isoxazoline derivatives useful as antimicrobials |
| 08/18/1999 | EP0936221A1 Novel 2,4-dioxopyrrolidine and 2,4-dioxotetrahydrofuran derivatives and medicines containing the same as the active ingredient |
| 08/18/1999 | EP0936216A1 Novel acetamide derivatives and protease inhibitors |
| 08/18/1999 | EP0935964A1 Pharmaceutical compositions containing NSAIDs and piperine |
| 08/18/1999 | EP0935963A2 The use of MMP-13 selective inhibitors for the treatment of osteoarthritis and other matrix metalloproteinase-mediated disorders |
| 08/18/1999 | EP0935962A1 Use of 5-(1,2-dithiolan-3-yl)valeric acid (alpha-lipoic acid) or its physiologically acceptable salts for treating lipid metabolism disorders |
| 08/18/1999 | EP0935961A2 (R)-2-(3-Benzoylphenyl)propionic acid salts and pharmaceutical preparations containing them |
| 08/18/1999 | EP0935667A1 Process for preparing docosahexaenoic acid and docosapentaenoic acid |
| 08/18/1999 | EP0935659A1 Compositions and methods for treating intracellular diseases |
| 08/18/1999 | EP0935654A1 Fibroblast growth factor homologous factor-3 (fhf-3) and methods of use |
| 08/18/1999 | EP0935612A1 Precursors of catalytic antibodies |
| 08/18/1999 | EP0935602A1 Pyrido (3,2,1-ij)-1,3,4-benzoxadiazine |
| 08/18/1999 | EP0935601A2 Arylamino fused pyridines and pyrimidines |
| 08/18/1999 | EP0935599A1 2-methoxyphenylpiperazine derivatives |
| 08/18/1999 | EP0935598A1 5-HETEROATOM-CONTAINING ALKYL SUBSTITUTED-3-OXO-PYRIDO(1,2-a) BENZIMIDAZOLE-4-CARBOXAMIDE DERIVATIVES USEFUL IN TREATING CENTRAL NERVOUS SYSTEM DISORDERS |
| 08/18/1999 | EP0935597A2 Dihydropyrones with improved antiviral activity |
| 08/18/1999 | EP0935469A1 Use of growth hormone |
| 08/18/1999 | EP0935468A1 Use of cytokines and cytotoxic substances in a new method to treat tumors |
| 08/18/1999 | EP0935466A1 Method and composition for inhibiting cellular irreversible changes due to stress |
| 08/18/1999 | EP0935465A1 Novel substituted imidazole compounds |
| 08/18/1999 | EP0935464A1 Inhibitors of farnesyl-protein transferase |
| 08/18/1999 | EP0935463A2 Anti-neurogenic inflammatory compounds and compositions and methods of use thereof |
| 08/18/1999 | EP0935462A1 Photopheresis treatment of leukocytes |
| 08/18/1999 | EP0935461A1 Use of adamantane amines or structurally similar compounds for combating borna disease virus and for the prevention and treatment of affective diseases and other disorders associated with bdv infections in humans and animals |
| 08/18/1999 | EP0935460A1 Taste masked pharmaceutical compositions |
| 08/18/1999 | EP0935458A1 Compositions containing at least one nucleic acid |
| 08/18/1999 | EP0935457A1 Preparation for the transport of an active substance across barriers |
| 08/18/1999 | EP0935417A1 Enteric formulations of proanthocyanidin polymer antidiarrheal compositions |
| 08/18/1999 | EP0935415A1 Methods for delivering compounds into a cell |
| 08/18/1999 | EP0896537B1 Preparation containing a combination of 5-methylisoxazole-4-carboxylic acid-(4-trifluoromethyl)-anilide and n-(4-trifluoromethylphenyl)2-cyano-3-hydroxycrotonic acid amide |
| 08/18/1999 | EP0804152B1 Lactulose lozenges |
| 08/18/1999 | EP0799174B1 Biocidal alcohols, their production and their use |
| 08/18/1999 | EP0796257B1 Malonic acid based matrix metalloproteinase inhibitors |
| 08/18/1999 | EP0789715A4 Complementarily bonded two- and three-dimensional supramolecular structures |
| 08/18/1999 | EP0779808B1 Triphenylethylenes for the prevention and treatment of osteoporosis |
| 08/18/1999 | EP0759026B1 Amide derivatives and their therapeutic use |
| 08/18/1999 | EP0724565B1 Novel spin trap nitronyl hindered phenols |
| 08/18/1999 | EP0703925B1 Production of antibody fragments |
| 08/18/1999 | EP0697869B1 Transdermal therapeutic systems for the administration of serotonin agonists |
| 08/18/1999 | EP0682662B1 Bicyclic carboxylic acid leukotriene b4 antagonists |
| 08/18/1999 | EP0679057B1 Structured lipids |
| 08/18/1999 | EP0666843B1 Sulfonylalkanoylamino hydroxyethylamino sulfamic acids useful as retroviral protease inhibitors |
| 08/18/1999 | EP0620817B1 Piperazine derivatives as 5-ht receptors antagonists |
| 08/18/1999 | EP0479822B1 Therapeutic nucleosides |
| 08/18/1999 | CN1226253A Steroid bisphosphonates |
| 08/18/1999 | CN1226252A Noval erythromycin derivative, method for preparing and use thereof as drugs |
| 08/18/1999 | CN1226249A Substituted bisindolylmaleimides for inhibition of cell proliferation |
| 08/18/1999 | CN1226248A Substituted bisindolylmaleimides for inhibition of cell proliferation |
| 08/18/1999 | CN1226247A Substituted bisindolyl maleimides for inhibition of cell proliferation |
| 08/18/1999 | CN1226246A Noval tricyclic N-cyanoimines useful as inhibitors of farnesyl-protein transferase |
| 08/18/1999 | CN1226245A Compounds with pharmacologically active, preparation method and use thereof |
| 08/18/1999 | CN1226236A New compounds |
| 08/18/1999 | CN1226234A New derivatives of 10,11-dihydro-10-oxo-5H-dibenz/b,f/azepine-5-carboxamide |
| 08/18/1999 | CN1226233A Non-ulcerogenic analgesic/anti-inflammatory clonixin derivative |
| 08/18/1999 | CN1226232A Acryloyl substituted distamycin derivative, process for preparing them, and use as antitumor and antiviral agents |
| 08/18/1999 | CN1226175A Sorbefaccients |
| 08/18/1999 | CN1226172A Method and compositions useful for inhibiting angiogenesis |
| 08/18/1999 | CN1226171A Type-2 chemokine binding proteins and methods of use thereof |
| 08/18/1999 | CN1226169A Use of uridine triphosphates and related compounds for prevention and treatment of pneumonia in immobilized patients |
| 08/18/1999 | CN1226168A Monophasic contraceptive method and kit comprising combination of progesterone and estrogen |
| 08/18/1999 | CN1226167A Biphasic comtraceptive method and kit comprising combination of progestin and estrogen |
| 08/18/1999 | CN1226166A Formulation and method for treating congestive heart failure |
| 08/18/1999 | CN1226165A Method for treating bipolar disorder |
| 08/18/1999 | CN1226164A Method for treating liver disease and like indications with vasodilating agent |
| 08/18/1999 | CN1226163A Formulation for treatment and/or prevention of dementia |
| 08/18/1999 | CN1226162A Coated trimebutine maleate tablet |
| 08/18/1999 | CN1226161A Drug for improving ocular circulation disorders |
| 08/18/1999 | CN1226160A Device for topical treatment of acne and its method of manufacture |
| 08/18/1999 | CN1226152A Transdermal propentofylline compositions for treatment of alzheimer's disease |
| 08/18/1999 | CN1225945A DNA encoding neospora dihydrofolate reductase-thymidylate synthase |
| 08/18/1999 | CN1225835A Oil-state fine medicinal powder preparation for treating carbuncle, sore and preparation method therefor |
| 08/18/1999 | CN1225828A External-use medicine for treating burn and scald of humanbody |
| 08/18/1999 | CN1225818A Safety pulp devitalizer |
| 08/18/1999 | CN1225817A Fibraurea element capsule preparation |
| 08/18/1999 | CN1225816A Moisture retaining agent and external-use agent for skin |
| 08/18/1999 | CN1044707C Substituted aminoalkylaminopyridine, preparation method, its use and medicinal composition containing same compound |
| 08/18/1999 | CN1044705C (1-phenyl-1-heterocyclyl) alkane derivatives and their preparation method and use |
| 08/18/1999 | CN1044680C Fish medicine for preventing and treating malignant diseases |
| 08/18/1999 | CN1044679C Benzothiophene compounds new use |
| 08/18/1999 | CN1044678C Oxo-phosphoric acid suspension production method |
| 08/17/1999 | US5939583 Antiarthritic agents; bone, cardiovascular, brain, nervous system disorders; antitumor and antimetastasis agents |
| 08/17/1999 | US5939567 Reacting stoiochiometric amount of fatty acid chloride or anhydride with taxane to attach the hydrocarbon chain to the hydroxy group at position 2' of taxane |
| 08/17/1999 | US5939560 Inhibitors of DP-mediated processes, compositions and therapeutic methods thereof |